Learn more: PMC Disclaimer | PMC Copyright Notice
Modern acupuncture-like stimulation methods: a literature review
Abstract
Acupuncture therapy has been proved to be effective for diverse diseases, symptoms, and conditions in numerous clinical trials. The growing popularity of acupuncture therapy has triggered the development of modern acupuncture-like stimulation devices (ASDs), which are equivalent or superior to manual acupuncture with respect to safety, decreased risk of infection, and facilitation of clinical trials. Here, we aim to summarize the research on modern ASDs, with a focus on featured devices undergoing active research and their effectiveness and target symptoms, along with annual publication rates. We searched the popular electronic databases Medline, PubMed, the Cochrane Library, and Web of Science, and analyzed English-language studies on humans. Thereby, a total of 728 studies were identified, of which 195 studies met our inclusion criteria. Electrical stimulators were found to be the earliest and most widely studied devices (133 articles), followed by laser (44 articles), magnetic (16 articles), and ultrasound (2 articles) stimulators. A total of 114 studies used randomized controlled trials, and 109 studies reported therapeutic benefits. The majority of the studies (32%) focused on analgesia and pain-relief effects, followed by effects on brain activity (16%). All types of the reviewed ASDs were associated with increasing annual publication trends; specifically, the annual growth in publications regarding noninvasive stimulation methods was more rapid than that regarding invasive methods. Based on this observation, we anticipate that the noninvasive or minimally invasive ASDs will become more popular in acupuncture therapy.
1. Introduction
Stimulation of acupoints and meridians has been an important therapeutic modality in traditional Eastern medicine, and it has also become popular in the West, as its clinical effectiveness has been demonstrated through extensive research. Acupuncture and related modern technologies are increasing in popularity worldwide. According to a 2002 World Health Organization report, acupuncture treatment was shown to be effective in controlled trials of 29 diseases, symptoms, or conditions.1 However, the safety of acupuncture has engendered controversy with respect to infection, inflammation, and pain management.
Clinical effectiveness of acupuncture has widely been studied during the past four decades.2, 3, 4, 5, 6 In addition to the demonstrated effectiveness of traditional acupuncture practices, increased demand has arisen for the development of modern acupuncture-like stimulation devices (ASDs), which are simpler to quantify and standardize and are less dependent on the manipulation techniques of individual clinicians.
The first modern ASD dates back to the early 1950s, which was based on electrical stimulation (ES).7, 8 In addition to its long history, ES is the most extensively studied ASD.9 Recently, however, several types of ASDs have extensively been studied for their clinical effectiveness and noninferiority to manual acupuncture, including laser stimulation (LS)10 and magnetic stimulation (MS).11 In this review, we summarize recent studies of popular ASDs. We first describe the most popular types of ASDs, discuss their clinical effectiveness and target symptoms, and finally, discuss the annual research trends regarding popular ASDs.
2. Methods
To analyze the popularity and features of methods for stimulation of acupoints, we searched for studies in the Medline, PubMed, Cochrane Library, and Web of Science electronic databases from their inception to June 2014. First, we searched for studies related to acupuncture or acupoint stimulation, which yielded > 22,000 studies, of which approximately 20,000 were redundant. Among the latter studies, approximately 3000 were related to moxibustion, 1600 to massage (or acupressure), 200 to the cupping method, 5400 to ES, 900 to LS, 700 to MS, and 300 to ultrasound stimulation (US). To narrow the search scope to ASDs, we refined the search to [(acupoint* or “acupuncture point*” or meridian*) and (stimul* or irritat* or excit* or response or respon* or react* or reflex or measur* or diagnos*) and (electric* electro* or magnet* or infrared or IR or laser or ultraviolet or UV or ultraso*) not (rat or monkey or dog or pig or cat or mouse or mice or rabbit or rodent*)]. We excluded laboratory experiments on animals, studies that were not written in English, and reviews. We searched 728 articles obtained from the electronic databases, excluding 489 articles that included studies on animals, manual acupuncture-only clinical trials, non-English-language articles, and review articles by screening the titles and abstracts. A total of 44 studies were excluded from the selected 239 articles because of duplication. Finally, 195 studies met the inclusion criteria and were evaluated in detail. The topics of these 195 articles were ES (133), LS (44), MS (16), and US (2), as shown in Fig. 1. Prior to describing the results of the detailed analysis, we introduce the features and research history of ES, LS, MS, and US in the following sections.
2.1. Electrical stimulation
Low electrical impedance and high conductance are recognized as typical electrical properties of acupoints and meridians.12, 13, 14 In the Western hemisphere, the electrical properties of acupoints and meridians have been investigated since the 1950s. In 1958, Niboyet and Mery15 reported the points with low skin impedance using the Wheatstone bridge, whereas in 1962, Kramar16 showed that acupoints have high capacitance compared with neighboring points. Voll7 devised an ES device to apply to acupoints and meridians, thereby establishing a method that was called “electroacupuncture according to Voll.” This method of Voll7 greatly stimulated clinical and research activities associated with ES at acupoints and meridians. In the East in 1956, Nakatani8 reported that electrical pathways connected the points with low skin resistance and named them “Ryodoraku.” Today, ES can be classified into five types: electroacupuncture (EA), transcutaneous electrical acupoint stimulation (TEAS), auricular electroacupuncture (AEA), transcutaneous electrical nerve stimulation (TENS), and electrical heat acupuncture (EHA). EA is an electrical, minimally invasive stimulation technique applied to acupoints. TEAS is an electrical, noninvasive stimulation technique applied to acupoints. AEA is a subtype of EA applied to acupoints of the ear. TENS is an electrical, noninvasive stimulation technique applied to the nervous system (nonacupoints). EHA is similar to EA with the exception that a needle heated by an electric current is used at acupoints. Of the 133 articles on ES, 54 pertained to EA, 69 to TEAS, six to AEA, three to TENS, and one to EHA. To simplify the discussion, we categorized ES into EAs and TEASs, where EAs represented all invasive techniques, such as EA, AEA, and EHA, and TEASs included all noninvasive techniques, such as TEAS, auricular TEAS, and TENS.
2.2. Laser stimulation
Studied since the 1970s, LS is used to expose acupoints of the human body to low-energy laser beams. A review article17 noted that studies using LS were conducted between 1970 and 1972 in the USSR. Nevertheless, Friedrich Plog's18 study published in 1976 is well known as the first report of implementation of LS at acupoints. Since the 1980s, LS has been recognized as an effective method for stimulating acupoints without needles. Applications of LS at acupoints were mostly described as noninvasive in the studies reviewed, with only a few being described as invasive. Here, we do not distinguish invasive techniques from noninvasive stimulation.
2.3. Magnetic and ultrasonic stimulation
MS is used to access the body's magnetic fields by stimulating acupoints, and MS of acupoints has been studied since the 1970s. Transcranial magnetic stimulation is one of the most frequently used MSs and was introduced by Barker19 in 1985. In 1980, Inoue20 applied for a patent for a device used for MS of body acupoints, and in 1982, Katayama21 reported the meridian magnetic analgesia of acupuncture stimulation (published in Japanese). The MS used in all 16 papers consisted of noninvasive stimulations at acupoints.
US is used to irritate acupoints using a narrow, cylindrical, high-frequency beam of sound. Characteristics of phonation and sound transmission in meridians were reported in the 1980s, and a study on US of acupoints was published by Jin22 in 1984. Only two studies that we identified in the electronic databases were relevant.
3. Results
The aforementioned four types of ASDs were classified into the following 13 categories according to the stimulation purposes: (a) analgesic effect; (b) pain relief; (c) physiological change; (d) improvement of the alimentary system; (e) prevention of nausea and vomiting; (f) recovery of muscle fatigue or improvement of muscle strength; (g) reduction of body weight; (h) treatment of depression; (i) treatment of addiction, such as addiction to tobacco, narcotics, and alcohol; (j) treatment of stroke; (k) treatment of various diseases; (l) characteristics of stimulation; and (m) brain activity. Fig. 2 shows how the four types of ASDs were distributed between the 13 categories for research purposes. It also shows the ratio of randomized controlled trials (RCTs) to efficacies for the 13 categories. The numbers shown in the uppermost boxes in Fig. 2 signify the numbers of articles. The numbers of overlapping articles are shown in parentheses under the 13 categories of the four ASDs, and the numbers in parentheses below the efficacy (%) are presented when the efficacy was unclear.
Distribution of the four ASDs with respect to the 13 research categories from (a) to (m) whereby the numbers of RCTs and the therapeutic effectiveness are shown for each category. Numbers reflect the article counts, with the numbers in parentheses for the four types indicating the number of cases of overlap between the stimulations, and the numbers in parentheses below the efficacy (%) are presented when the efficacy was unclear. In RCT (%) = A/(A + B) % and (O:X = A:B), A is the number of RCTs and B is the number of non-RCTs. The same formula was applied to the efficacy percentages. When the efficacy was unclear, indicated by the numbers in parentheses, we considered those studies as not effective in computing the percent values. For example, % value = A/(A + B + b) for efficacy [O:X = A:B(b)].
ASD, acupuncture-like stimulation device; ES, electrical stimulation; LS, laser stimulation; MS, magnetic stimulation; RCT, randomized controlled trial; US, ultrasound stimulation. O = yes, X = no. Example: RCT (O:X) = (RCT:non-RCT), Efficacy (O:X) = (efficacious:not efficacious).
To investigate the effectiveness of ASDs, we analyzed the efficacy of each stimulation type through the articles reporting effectiveness. The effectiveness of ES was stated in the fields of analgesic effect (94.7%), pain relief (90.9%), and reduction of nausea and vomiting (90.9%) based on the sample size of > 1000 trials. Based on the sample size of > 100 trials, ES was shown to be effective in improving the alimentary system (100%), improving muscle strength (100%), reducing body weight (100%), treating various addictions (60%), and treating stroke (100%), whereas LS was effective for pain relief (62.5%) and treating various addictions (100%). Based on a sample size of <100 trials, ES was shown to be a therapeutic possibility in various diseases such as orthostatic intolerance, autism spectrum disorders, supratentorial craniotomy, tinnitus, asthma, dyspnea, distress, and anxiety. LS presented potential in the treatment of nausea and vomiting, depression, menopausal symptoms, cholecystitis, renal failure, head injury, and interstitial cystitis. MS was a possible treatment for muscle and diving fatigue, whereas US demonstrated potential for relieving pain.
3.1. Analgesic effect
All the studies that reported an analgesic effect are shown in Table 1. Twelve articles reported an analgesic effect using TEASs,23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 seven articles reported an analgesic effect using EAs,35, 36, 37, 38, 39, 40, 41 and two articles discussed LS.42, 43 A total of 834 individuals received TEASs to enable estimation of the analgesic effect of their clinical application using RCTs, and all articles reported that the TEASs had an analgesic or hypoalgesic effect or decreased opioid requirements. A total of 348 individuals received EAs, and an effect of the EAs on analgesia, sedation, hypoalgesia, pre-emptive analgesia, and reduction of analgesic requirements was found in 334 patients. In 20 individuals who received acupressure, manual acupuncture (MA), and LS, a sedative effect was observed, and an anesthetic effect was observed in 60 individuals who received LS. Two of the 21 papers39, 43 reported no significant analgesic effect of the EAs and LS.
Table 1
Summary of studies on analgesic effects with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Jiang et al23 | TEAS | LI4, PC8 | Healthy | 46 individuals, TEAS/mock TEAS | Analgesic effect |
| Wang et al24 | TEAS | LI4, PC6, ST36 | Sinusotomy | 60 patients, random TEAS/control: no stimulation | Analgesic effect |
| Zhang et al25 | TEAS | T3 acupoints | Ambulatory surgery | 72 women, random TEAS/sham | Recovery & decrease of anesthesia |
| Wu et al35 | EA | GV1, BL57 | Hemorrhoids | 120 cases, random EA (40)/sham EA (40)/blank (40) | Effects of preemptive analgesia |
| Lan et al26 | TEAS | Bi PC6, LI14, ipsilateral to surgery sire ST36, GB31 | Total hip arthroplasty surgery | 68 elderly patients, random TEAS/sham TEAS | Reduction of postoperative analgesic requirement |
| Zheng et al36 | EA | GV24, EX-HN3 | Orotracheally intubated patients | 45 patients, random, no treatment/sham EA/EA | Sedation & analgesia |
| Cheing and & Chan27 | TEAS/TENS | Right elbow LI11, Nonacupoint (right superficial radial nerve) | Healthy | Randomized controlled trial, 45 individuals, random TEAS (15)/TENS (15)/control-no stim (15) | Hypoalgesic effects (acupuncture points & nerve points) |
| DeSantana et al31 | TENS | Around the incision | Unilateral inguinal herniorrhaphy with epidural anesthetic technique | Prospective, randomized, double-blinded, placebo-controlled study, 40 patients, TENS (20)/placebo-TENS (20) | Hypoalgesic effect for postoperative pain |
| Barlas et al37 | EA | Bi LI10, HT5/ipsilateral GB34, ST38 | Healthy (acupuncture naïve) | Randomized, double-blinded, placebo-controlled study, 48 volunteers, control/placebo-EA no stim/high-intensity EA/low-intensity EA | Hypoalgesic response |
| Leung et al40 | EA | Left SP1, LR1 | Healthy | 13 individuals, EA/before-EA/ after-EA (time sequence) | Analgesic benefit |
| Litscher42 | Acupressure/MA/LS | EX-HN3 | Healthy | Randomized, controlled, blinded crossover trial, 20 volunteers, acupress/MA/LA; APs/non-APs | ECG similarities of acupressure-induced sedation & general anesthesia (all) |
| Zhang et al38 | EA | Acupoints | Healthy | Eight8 individuals, EA/mock-EA | Analgesic effect |
| Attele et al28 | TEAS | LI4, PC6 | Healthy | 22 individuals, TEAS/control | Analgesic effect |
| Chesterton et al29 | TENS/TEAS | GB34, radial nerve or extrasegmental | Healthy | Randomized, double-blind, sham-controlled study, 240 participants, six6 TENS (180; 90 m, 90 f)/control (30; 15 m, 15 f)/sham TENS (30; 15 m, 15 f); 4/110 Hz, intensity, site | Hypoalgesic effect |
| Yuan et al30 | TEAS | LI4, PC6 | Healthy | 20 individuals TEAS/morphine/TEAS + morphine/control | Analgesia effect |
| Morioka et al39 | EA | ST36, GB34, BL60 | Healthy | 14 volunteers, EA/control | No difference in minimum alveolar anesthetic concentration |
| Lin et al41 | EA | Bi ST36 | Lower abdominal surgery | Randomly, 100 women, control (25)/sham-EA no stim (25)/LF-EA 2 Hz (25)/HF-EA 100 Hz (25) | Reduction of postoperative analgesic requirements & side effects (LF-EA, HF-EA) |
| Greif et al32 | ATEAS | Auricular acupoints | Healthy | Randomized, double-blind, crossover trial, 20 volunteers (10 m, 10 f), ATEAS/no treatment | Reduction of anesthetic requirement |
| Chen et al33 | TEAS/TENS | ST36/dermatomal level | Total abdominal hysterectomy or myomectomy procedures | Randomized controlled trial, 100 women, sham-TEAS no stim (25)/non-APs TEAS (25)/dermatomal-TENS (25)/TEAS (25) | TENS was as effective as TEAS, both were more effective than stim at non-APs |
| Wang et al34 | TEAS | LI4 | Healthy women undergoing lower abdominal procedures | Random, 101 participants, PCA (26)/PCA + LP-TEAS (25)/PCA + HP-TEAS (25)/PCA + sham-TEAS no stim (25) | Decrease in PCA opioid requirement & opioid-related side effects (HP-TEAS) |
| Brokhaus and& Elger43 | LS/MA | Bi LI4, EX-UE | Healthy | Double-blind, 40 probationers, MA-LI4/LA-LI4, EX | Analgesic effect of MA on painful heat stim, no effect on pain (LA) |
AP, acupuncture point; ASD, acupuncture-like stimulation device; ATEAS, auricular TEAS; EA, electroacupuncture; ECG, electrocardiogram; HF, high frequency; HP-TEAS, high power TEAS; LA, laser acupuncture; LF, low frequency; LP-TEAS, low power TEAS; LS, laser stimulation; MA, Manual acupuncture; PCA, patient-controlled analgesia; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation.
3.2. Pain relief
As shown in Table 2, presenting the studies reporting the effect on pain relief, 15 articles reported using TEASs,44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58 EAs were used in 18 studies,59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76 other acupoint stimulations such as US were used in one study,77 and LS was used in eight studies.78, 79, 80, 81, 82, 83, 84, 85 TEASs and EAs were compared in a total of 872 individuals to evaluate their effect on pain relief. Both had an effect on pain relief in two studies; however, the effect of EAs was reported to be superior to that of TEASs in one study. Of 1046 individuals who received TEASs, 926 experienced relief or a reduction in various types of pain. Of the 877 individuals who received EAs, 628 also experienced pain relief. Of the 435 individuals who received LS, 230 experienced relief of dysmenorrhea pain or carpal tunnel syndrome pain, whereas 50 individuals who received US experienced an effect on short-term segmental antinociception. Six of the 42 papers44, 47, 64, 79, 82, 84 reported no statistically significant effect on pain relief when TEASs, LS, EAs, LS combined with paracetamol and chlormezanone, and LS were applied to the acupoints of study participants.
Table 2
Summary of studies on pain relief with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Mucuk & Baser 44 | TEAS | LI4, SP6 | Pregnant women | Bi LI4-TEAS (40)/SP6-TEAS (40)/control (40) no stim | Labor pain relief, not statistically significant |
| Sun et al45 | TEAS | PC6 | Driver fatigue | – | Able to withstand driver fatigue |
| Vassal et al46 | TENS | Left common peroneal nerve | Healthy | 20 individuals, TENS/sham TENS (left thigh) | Pain relief |
| Kim et al59 | EA | Bi LI4, TE3, GV39, GV41, SP6, LR3, Ba Feng, Ba Xie | CIPN | Randomized, patient-assessor-blinded, controlled trial, 40 patients, EA (20)/sham EA (20) | Treatment for CIPN, trials |
| Lee et al60 | EA | Bi ST36, GB39, SP9, PC6, LR3, GB41 | PDN | 3-armed, randomized, controlled pilot trial, EA (15)/sham EA (15)/usual care (15) | Treatment for PDN, trials |
| Mucuk et al47 | TEAS | Bilateral LI4 | Labor pain | Random TEAS/control no TEAS; all standard treatments | Pain relief, not statistically significant |
| Ni et al48 | TEAS | Bilateral PC6 | Children with congenital heart defects | 70 eligible children, random, TEAS (34)/control-no stim (36) | Attenuation of myocardial injury in children undergoing cardiac surgery |
| Wu et al49 | TEAS | LI4, SP6 | Gynecology patients (primary dysmenorrhea) | Randomized controlled trial, 66 patients (f), TEAS (34)/control non-APs (32) | Mitigation of pain in dysmenorrhea |
| Yoshimizu et al72 | EA/TEAS | For acupoints in trapezius muscle | Shoulder & neck pain | Randomized crossover trial, 90 patients, EA/TENS | Reduction in pain (EA > TEAS) |
| Musial et al73 | EA | LI4, LI10 | Healthy | Double-blind design, 125 individuals, EA (25)/tramadol (25)/ibuprofen (25)/placebo pill (25)/no treatment (25) | Reduction of experimentally induced ischemic pain |
| Choi et al61 | EA/meditation | LI4, LI10 | Vipassana meditators | Semirandomized trial, meditators(8)/nonmeditators (20)-EA/nonmeditators (20)- no EA | Reduction in the pain induced by SETT |
| Yeh et al50 | TEAS | BL40, GB34, HT7, PC6 | Spinal surgery receiving patients | Placebo- & sham-controlled study, random TEAS (30)/TEAS-sham point (30)/no TEAS (30) | Reduction in postoperative pain, analgesic usage |
| Montenegro et al51 | TEAS | TE5, CV6 | Healthy | 32 volunteers, random TEAS/sham TEAS | Increase in the latency of pain threshold |
| Yeh et al53 | TEAS | Acupoints | Lumbar spinal surgery | Randomized controlled repeated measures design, 99 patients, ES/sham-AP ES/no ES | Improvement of acute postoperative pain management without adversely affecting vital signs |
| Takamjani et al81 | LS | Acupoints | Wrist pain | Randomized controlled trial, 70 women, LS (33)/control (37) no LS | Increase in mean value of pain threshold |
| Lee & Lee62 | EA | Bi BL32, BL33, GB30 | Chronic prostatitis/chronic pelvic pain syndrome | 39 men, random 3 group exercise + EA/exercise + sham EA/exercise | Pain relief effect |
| Kempf et al78 | LS | Bi SP6, LR3, LI4; right CV3, ST36 | Minimum menstrual pain | Randomized controlled double blind pilot trial, 48 women, LA (18)/placebo-LA (30) | Dysmenorrhea treatment |
| Glazov et al82 | LS | Acupoints | Chronic nonspecific low-back pain | Double blind, 2-group parallel randomized controlled trial, 100 participants, LA/sham-LA | Not showing a specific effect for chronic low-back pain |
| Chan et al74 | EA | Acupoints on the wrist | Chronic neck pain | Single-blind, randomized, sham-controlled trial, 49 patients, EA (22)/sham-EA (27) | Significant improvements of chronic neck pain |
| Jubb et al63 | EA | Acupoints | Osteoarthritic knee pain & disability | Blinded randomized trial, MA (34)/EA (34)/sham MA (34) | Symptomatic improvement |
| Srbely et al77 | US | Right supraspinatus trigger point | Identifiable myofascial trigger points | Randomized controlled study, 50 individuals, random US/sham US (off) | Short-term segmental antinociceptive effects on TPs |
| Ye et al54 | TEAS + PCA | LI4, PC8; Jiaogan, Shenmen, Shen, Waifei, Naogan, Pizhixia (ear acupoints) | Craniotomy & required pain relief following surgery | Randomized control, 40 patients, PCA + TEAS (20)/PCA (20) | Enhancement of the effect of pain relief & reduction of adverse reactions |
| Michalek-Sauberer et al64 | AEA | Auricular shenmen, mouth, tooth | Molar tooth extraction | Prospective, randomized, double-blind, placebo-controlled study, 149 patients, AEA (76)/AMA (37)/sham AEA no stim no needle (36) | No reduction in either pain intensity or analgesic consumption in a molar tooth extraction model |
| Zhang et al65 | EA | GB34, GB39 | Healthy (right handiness) | 12 volunteers, EA/sham-points EA/shallow EA subcutaneous needling | Pain relief |
| Yip et al55 | TEAS + EMMW | – | Subacute neck or low-back pain | Randomly, 47 individuals, TEAS + EMMW (23)/control (24) | Reduction in pain intensity, stress, & stiffness level |
| Fang et al52 | TEAS/EA | Acupoints | Periarthritis of shoulder at different stages | 360 cases, TEAS (186)/EA (174) | Therapy for periarthritis of shoulder, no significant differences (TEAS/EA) |
| Aigner et al79 | LS + paracetamol, chlormezanone | 22 acupuncture points | Whiplash injuries | Prospective, randomized placebo-controlled trial, LA (23)/placebo-LA (22) | Ineffective in management of whiplash injuries |
| Sator-Katzenschlager et al66 | AEA | Auricular 29, 55, 57 | In vitro fertilization | 94 women, random, AEA (32)/AMA (32)/pharm. (30) | Reduction of pain intensity |
| Wong et al75 | EA | LI4, GB34, GB36, TE8 | Operable non-small cell lung carcinoma patients who received thoracotomy | Random, 25 patients, EA (13)/sham-EA (12) | Management of post-thoracotomy wound pain |
| Weng et al56 | TEAS | LI10, LI11 | Tennis elbow pain for at least 3 mo | Randomly, 20 patients, 5 kHz modulated LF-TEAS 2 Hz (20)/5 kHz modulated HF-TEAS 100 Hz (20)/sham-TEAS, different time slots | Effective in the treatment of patients with tennis elbow pain (LF-TEAS, HF-TEAS) |
| Tsui & Cheing67 | EA/EHA | 6 acupuncture points | Chronic low-back pain | 42 individuals, random EA/EHA/control; all exercise | Treatment of chronic low-back pain |
| Sator-Katzenschlager et al68 | AEA | Auricular acupuncture points 29, 40, 55 | Chronic low-back pain | Prospective, randomized, double-blind, controlled study, 61 patients, random AEA (31)/sham-AEA no stim (30) | Treatment of chronic low-back pain |
| Sator-Katzenschlager et al69 | AEA | Cervical spine, shenmen, cushion | Chronic cervical pain patients without radicular symptoms with insufficient pain relief | Prospective, randomized, double-blinded, controlled study, 21 patients, EA (10)/control (11) | Treatment of chronic cervical pain |
| Ng et al70 | EA/TEAS | ST35/EX-LE4 | OA-induced knee pain | Single-blinded randomized controlled trial, 24 individuals (1 m, 23 f), EA (8)/TEAS (8)/control standard therapy (8) | Reduction of OA-induced knee pain |
| Naeser et al80 | LS/TENS | Shallow acupuncture points/wrist | CTS | Randomized, double-blind, placebo-controlled, crossover trial, 11 cases, red LS/IR LS/TEAS/sham (off) | Treating CTS pain |
| Tsui & Leung 71 | EA | GB34, ST38 | Chronic tennis elbow | Single-blinded randomized controlled trial, 20 patients, MA/EA | Treating patients with tennis elbow |
| Zoghi & Jaberzadeh57 | ATEAS/ATENS | 4 auricular acupoints | Healthy | Double-blind within-subject design, randomly, 90 individuals, HV-ES (30)/HV-sham-ES non-APs (30)/no ES (30) | Increase in experimental pain threshold (HV-ES, sham) |
| Lorenazana58 | TEAS | HT7, LI4 | Episiotomy pain | Randomized, double-blind, controlled trial, 68 patients, TEAS (38)/control (30) | Relief of episiotomy pain (TEAS > lidocaine) |
| King et al83 | ALS | Auricular acupoints | Healthy | 80 individuals, ALS (41)/control (39) sham-ALS | Increase in mean pain threshold after treatment |
| Waylonis et al84 | LS | Acupoints | Myofascial pain syndromes (fibrositis, fibromyalgia) | Crossover double-blind trials, 62 patients, LS/placebo | No statistical difference between the treatment and placebo groups |
| Kreczi & Klingler85 | LS | Acupoints | Radicular and pseudoradicular pain syndromes | Prospective randomized single-blind crossover study, 21 patients, LS/mock LS | Mean pain levels (lower) |
| Ernst & Lee76 | EA | LI4 | Normal individuals | Crossover repeated-measure design, 5 individuals, control/EA/EA + naloxone/EA + placebo | Pain threshold increase |
AEA, auricular electroacupuncture; ALS, auricular laser stimulation; AMA, auricular manual acupuncture; AP, acupuncture point; ASD, acupuncture-like stimulation device; ATEAS, auricular TEAS; ATENS, auricular TENS; CIPN, chemotherapy-induced peripheral neuropathy; CTS, carpal tunnel syndrome; EA, electroacupuncture; EHA, electrical heat acupuncture; EMMW, electromagnetic millimeter wave; ES, electrical stimulation; f, female; m, male; HF, high frequency; HV, high voltage; IR, infrared; LA, laser acupuncture; LF, low frequency; LS, laser stimulation; MA, manual acupuncture; OA, osteoarthritis; PCA, patient-controlled analgesia; PDN, painful diabetic neuropathy; pharm, pharmacological treatment; SETT, submaximum effort tourniquet technique; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation; TP, trigger point; US, ultrasound stimulation.
3.3. Treatments of the alimentary system
As summarized in Table 3, ES (TEASs and EAs) was the primary ASD method for treating digestive disorders. Of these studies, seven that investigated TEAS86, 87, 88, 89, 90, 91, 92 and three that evaluated EA93, 94, 95 comprise this category. In total, 149 individuals who received TEAS experienced a beneficial effect on the alimentary system, as did 68 individuals who received EA. No study reported statistically insignificant results regarding stimulation of the alimentary system.
Table 3
Summary of studies on the effects of the four ASDs on alimentary system
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| McNearney et al86 | TEAS | PC6, ST36 | SSc | 17 patients, all TEAS | Enhancement of gastric myoelectrical functioning in SSc |
| Leung et al87 | TEAS | LI4, PC6, ST36 | Healthy | 40 individuals, random TEAS/placebo TEAS | Reduction of rectal discomfort |
| Chen et al93 | EA | ST36, ST37, ST25, ST28, CV4, CV6 | Female constipation | Single-blind, randomized trial, 30 females, EA (14)/sham EA (16) | Improvement of constipation |
| Liu et al88 | TEAS | PC6, ST36 | Functional dyspepsia | Double-blind, crossover study, 27 patients, random acute-TEAS/chronic (2w) TEAS | Improvement of dyspepsia symptoms |
| Wang et al94 | EA | ST36, LI4 | Type 2 diabetes (symptoms of gastroparesis) | Single-blind, randomized pilot study, 19 patients, EA (9)/sham EA (10) | Reduction of the dyspeptic symptoms of diabetic gastroparesis |
| Sallam et al89 | TEAS | Gastrointestinal (GI) acupoints | SSc | 17 patients, TEAS/baseline | Treatment of upper GI symptoms |
| Xu et al95 | EA | ST36, PC6 | Functional dyspepsia | 19 patients, acute-EA (10)/short-term (2w) EA (9) | Relief of dyspeptic symptoms |
| Zou et al92 | TEAS | PC6 | Healthy | Random, 26 volunteers, TEAS/sham APs-TEAS/naloxone | Inhibition of frequency of transient lower esophageal sphincter relaxations |
| Xing et al90 | TEAS | ST36, PC6 | Diarrhea-predominant IBS | 7 patients, TEAS/sham-TEAS/control | Reduction of rectal sensitivity in IBS patients |
| Chang et al91 | TEAS | ST36 | Healthy (males) | 15 volunteers (males) EA/TEAS | Enhancement of gastric myoelectrical regularity, bradygastria not significant |
AP, acupuncture point; EA, electroacupuncture; GI, gastrointestinal; IBS, irritable bowel syndrome; SSc, scleroderma; TEAS, transcutaneous electrical acupoint stimulation.
3.4. Prevention of nausea and vomiting
All the studies shown in Table 4 employed ASDs for the prevention of nausea and vomiting. ES was primarily applied for the prevention or treatment of nausea and vomiting, except for one study that used LS for this purpose. TEAS was the main method used for preventing nausea and vomiting: we retrieved nine articles on TEAS,96, 97, 98, 99, 100, 101, 102, 103, 104 two on EA,105, 106 and one on LS.107 A total of 830 individuals who received TEAS experienced an effect on prevention, reduction, or treatment of postoperative nausea and vomiting and nausea or vomiting. A total of 224 individuals who received EA also experienced either the same effect or controlled emesis, whereas 40 individuals who received LS experienced a decrease in the incidence of vomiting. We observed that TEAS has been steadily applied in the prevention of nausea and vomiting, and exceeded EA in the number of clinical studies since 2003. This finding implies that the effectiveness of TEAS in preventing nausea and vomiting has been confirmed, and that TEAS was preferred to EA because of the infection risk and pain due to the use of needles with EA.
Table 4
Summary of studies on the effects of the four ASDs on nausea and vomiting
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Xu et al96 | TEAS | PC6 | PONV | Prospective, blind, & randomized study, 119 patients, TEAS/sham TEAS | Prevention of PONV after infratentorial craniotomy |
| Wang et al97 | TEAS | Right PC6 | Supratentorial craniotomy | Random TEAS (40)/control-nonacupoint (40),all standard general anesthesia | Prevalence of nausea, vomiting |
| Larson et al98 | TEAS | Acupuncture points | Patients undergoing cosmetic surgery | Prospective, randomized, blinded, clinical trial, 122 patients, random standard pharm./pharm. + EA | Postoperative nausea & vomiting |
| Liu et al99 | TEAS | Left-side PC6 | Patients undergoing laparoscopic cholecystectomy | 96 patients, random EA/placebo-EA no stim | Reduction of nausea & vomiting, pain relief |
| Habib et al102 | TEAS | PC6/dorsum of wrist | Cesarean delivery with spinal anesthesia | Random, 91 patients, TEAS (47)/sham-APs TEAS (44) | No difference between the 2 groups (less PONV in 2 groups) |
| Kabalak et al100 | TEAS | PC6, CV13 | Tonsillectomy under general anesthesia | Randomized, controlled, prospective study, 90 children, TEAS (30)/pharm. dose (30)/no treatment (30) | Prophylaxis of postoperative retching & vomiting in pediatric tonsillectomy |
| Kramer et al101 | TEAS | PC6 | Patients receiving electroconvulsive therapy | 11 patients, TEAS (9 good, 1 mixed, 1 no response) | Treating nausea & vomiting |
| Rusy et al105 | EA | PC6 | Tonsillectomy | 120 patients, random EA (40)/sham-EA sham needle(40)/control no needle (40) | PONV prevention |
| Zárate et al103 | TEAS | PC6 | Laparoscopic cholecystectomy with standardized general anesthetic technique | Sham-controlled, double-blinded study, random, 221 outpatients, TEAS/placebo no stim | TEAS reduced postoperative nausea, but not vomiting |
| Shen et al106 | EA | Antiemetic acupoints | High-risk breast cancer patients undergoing highly emetogenic chemotherapy regimen | 3-arm, parallel-group, randomized controlled trial, LF-EA (37)/mock-EA (33)/no-EA (34) | Effective in controlling emesis (EA > pharm.) |
| Schlager et al107 | LS | Bi PC6 | Postoperative vomiting in children undergoing strabismus surgery | Double-blind, randomized, controlled study, 40 children, LS (20)/placebo (20) | Incidence of vomiting significantly lower |
| McMillan & Dundee104 | TEAS | PC6 | Cancer chemotherapy | – | Antiemetic action, useful adjunct to both the older antiemetics & the new antagonist ondansetron |
ASD, acupuncture-like stimulation device; EA, electroacupuncture; LF, low frequency; PONV, postoperative nausea and vomiting; pharm, Pharmacological; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation.
3.5. Improvement of the muscle system
Studies regarding ASDs that were related to the recovery of muscle fatigue or improvement of muscle strength are shown in Table 5. MS and ES were used to reduce muscle fatigue or improve muscle strength. This category included two studies on MS108, 109 and five studies110, 111, 112, 113, 114 on ES. The two MS studies, which were conducted by the same research group, reported the effective recovery of muscle fatigue. One study109 reported better performance of MS than TEAS with respect to the therapeutic effect on muscle fatigue, and we expect more studies to validate this report.
Table 5
Summary of studies on the recovery of muscle fatigue or improvement of muscle strength with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Kim et al108 | MS | LR9 | Healthy (males) | 20 participants (males), MS (10)/no MS (10) | Recovery of muscle fatigue |
| Kim et al109 | TEAS/MS | An acupoint | Muscle fatigue | TEAS/MS/no stim | Therapeutic effect on muscle fatigue (MS better) |
| Zhou et al110 | EA | ST36, ST39 | Healthy (males) | randomized controlled trial, 43 young men, control/MA/ EA-APs/EA-non-APs | Improvement of muscle strength in both limbs |
| Ngai et al111 | TEAS | Bi LU7, EX-B1 | Healthy (males) | 11 individuals (males), TEAS/placebo-TEAS no stim | Higher postexercise FEV1, prolongation of submaximal exercise |
| Huang et al112 | EA | ST36, ST39 | Healthy (males) | 30 men, random EA/control | Improvement of muscle strength of both limbs |
| Chiu et al113 | TEAS + LS/exercise + LS/LS | Acupoints | Chronic neck pain | Randomized clinical trial, 218 patients, TEAS + IR/Exercise + IR (LS)/IR (LS) | Improvement in disability, isometric neck muscle strength, pain (TEAS, exercise) |
| Milne et al114 | TEAS/EA | LI4, LI11 | Healthy | TEAS/EA | Relief of muscle spasm & musculoskeletal pain, & restoration of mobility (TEAS) |
AP, acupuncture point; ASD, acupuncture-like stimulation device; EA, electroacupuncture; FEV1, forced expiratory volume in 1 second; IR, infrared; stim, stimulation; LS, laser stimulation; MA, manual acupuncture; MS, magnetic stimulation; TEAS, transcutaneous electrical acupoint stimulation.
3.6. Reduction in body weight
All the papers investigating the reduction in body weight were associated with ES, as shown in Table 6. EAs115, 118, 119 and TEASs116, 117 were applied to facilitate the reduction in body weight. One study117 stated that TEAS was as effective as EA in weight reduction. A total of 193 individuals who received ES experienced a reduction in body weight or fat, and an improvement in body mass index or body composition. All the studies reporting on the reduction in body weight claimed significant effects. More studies are required to substantiate the effectiveness of ES for body weight reduction.
Table 6
Summary of studies on the reduction in body weight with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Schukro et al115 | AEA | 18, 87, 91 at ear | Obese females | Prospective, randomized, double-blinded study, 56 patients (females), AEA (28)/placebo dummy (28) | Reduction of body weight & BMI |
| Chien et al116 | TEAS | ST36 | Postmenopausal obese women | Prospective study, 49 women, random TEAS (24)/control no-TEAS (25) | Reduction in percentage body fat |
| Rerksuppaphol & Rerksuppaphol117 | TEAS/EA | 10 acupoints | Obese women | Prospective randomized open-label study, 45 women, TEAS/EA | Effective method for weight reduction as seen with EA |
| Lin et al118 | EA | ST36, SP6 | Postmenopausal women with obesity | Randomized controlled trial, 41 women, EA (20)/control (21) | Improvement of body composition |
| Jeong & Lee119 | EA | Acupoints | Factitial panniculitis | 2 cases (females), EA | Weight reduction |
AEA, auricular electroacupuncture; ASD, acupuncture-like stimulation device; EA, electroacupuncture; TEAS, transcutaneous electrical acupoint stimulation.
3.7. Treatment of depression, addiction, and stroke
Two studies investigating the treatment of depression using LS,120, 121 five studies evaluating the treatment of various addictions (i.e., alcoholism and addictions to tobacco and narcotics) using ES122, 123, 124 and LS,125, 126 and four studies examining the treatment of stroke using ES127, 128, 129, 130 are shown in Table 7, Table 8, Table 9, respectively. LS was used by a research group to treat depression120, 121, whereas two studies used ES devices123, 124, one used LS125 to treat tobacco dependence, one used an ES device in the treatment of drug abuse,122 and one used LS to treat alcoholism.126 Five studies showed that the use of ES and that of LS for treating various addictions were appropriate treatment adjuncts. ES was applied for treating stroke in four studies. All the studies in which stroke was treated, including treatment with a combination therapy consisting of TEAS and task-related training, reported treatment efficacy of TEAS or EA based on clinical trials involving 421 individuals. These results showed that ES is feasible for treating stroke. All the studies in these three categories claimed beneficial effects on the treatment of depression, various addictions, or stroke.
Table 7
Summary of studies on the treatment of depression with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Quah-Smith et al120 | LS | LR14, LR8, CV14, HT7 | Depressed participants | Random block on–off design, 10 nondepressed participants, 10 depressed participants | Antidepressant effect |
| Quah-Smith et al121 | LS | LR14, CV14, LR8, HT7, KI3 | major depressive disorder | Randomized, double blinded, placebo controlled trial, 47 participants, LA/placebo LA | Reduction of symptoms of depression |
ASD, acupuncture-like stimulation device; LS, laser stimulation.
Table 8
Summary of studies on the treatment of smoking and addiction of drug and alcohol with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Penetar et al122 | TEAS | PC6, TH5; LI4, PC8 | Cocaine dependent or cannabis dependent | Single-blind, sham-controlled, crossover design, 20 volunteers (11 m, 9 f) TEAS/sham-TEAS/baseline ST | Modulation of mood & anxiety, no significant reduction in drug use or drug cravings |
| Lambert et al123 | TEAS | LI4, PC8, PC6, TE5 | Smoking | 2 double-blind studies, 98 smokers, random TEAS-10 mA (20)/TEAS-5 mA (20)/placebo TEAS-0 mA (16)/TEAS-5 mA (19); intermittent 5 mA | Antagonizing the urge to smoke in dependent smokers |
| Kerr et al125 | LS | 4 acupoints | Smoking | Double-blind, randomized controlled trial, 387 volunteers, 3-LS 1-sham LS/4-LS/4-sham LS no stim | Assisting in smoking cessation by reducing the physical symptoms of withdrawal |
| Zalewska-Kaszubska & Obzejta126 | ALS | Neck; 10 auricular acupoints | Alcoholics | 53 patients, He–Ne LS (neck) + argon ALS | Adjunct treatment for alcoholism |
| Georgiou et al124 | TEAS | SJ18, SJ17 | Smoking cessation | Randomized controlled trial, 216 smokers, TEAS/control TEAS no stim | Insufficient power to detect real but small differences between treatment conditions |
ALS, auricular laser stimulation; ASD, acupuncture-like stimulation device; f, female; LS, laser stimulation; m, male; stim, stimulation; ST, standard treatment; TEAS, transcutaneous electrical acupoint stimulation.
Table 9
Summary of studies on the treatment of stroke with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Ng & Hui-Chan127 | TEAS + TRT | ST36, LV3, GB34, UB60 | Poststroke | Case study, 1 man (age 61 y), TEAS + TRT | Decreased impairment & improved function in an individual with long-term chronic stroke |
| Gong et al128 | EA | ST36 | First-time cerebral infarction or hemorrhage, or a stroke history | Randomized, controlled, clinical study, 240 patients, EA (124)/control (116) | Effects on lower extremity motor function in stroke patients |
| Kim et al129 | TEAS | Acupoints | Ischemic stroke with motor dysfunction | 62 patients, 2 Hz-TEAS/120 Hz-TEAS | Helpful for motor recovery after ischemic stroke (LF-TEAS) |
| Wong et al130 | TEAS | Acupoints | Patients with hemiplegia in stroke | Randomized, 118 patients, comprehensive rehabilitation + TEAS (59)/comprehensive rehabilitation (59) | Convenient & effective therapy for stroke |
ASD, acupuncture-like stimulation device; EA, electroacupuncture; LF, low frequency; TEAS, transcutaneous electrical acupoint stimulation; TRT, task-related training.
3.8. Physiological changes, diverse diseases, miscellaneous characteristics, and brain activities
All the papers regarding ASDs that induced physiological changes, treated various diseases, affected miscellaneous characteristics, and induced brain activities are shown in Table 10, Table 11, Table 12, Table 13,131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174 respectively. Most studies in these categories were focused on phenomenological observations or consisted of a small number of clinical trials. Many more case studies are required to demonstrate the effects of ASDs on diverse diseases. These various investigations may expand the application of modern ASDs. Due to the limited scope of this review, we did not further investigate the diverse aspects of these studies.
Table 10
Summary of studies on physiological changes with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Cafaro et al131 | LS | Bi LI2, ST5, ST6, ST7, SI19, BL 13 | Sjögren's syndrome | 26 female, patients, LA/sham | Salivary flow rate improvement |
| Kim et al175 | MS | LI4 | Healthy | – | Improvement of peripheral vascular system circulation |
| Li et al176 | EA | LI4, TE5, BL63, LR3, ST36, BL40, BL10, BL20, BL2, EX-HN4 | Supratentorial craniotomy | 29 patients, control (10)/EA (9)/sham EA (10) | Prevention of decrease of immunoglobulin after surgery, no significant difference between EA & sham EA |
| Litscher et al132 | LS | GV20, PC6 | Healthy | Randomized crossover study, 11 volunteers (3 m, 8 f), MA (GV20;PC6)/red LA (GV20;PC6)/violet LA (GV20;PC6) | HR & HRV control |
| Tsuruoka et al177 | US | LR3 | Healthy | 50 volunteers (40 m, 10 f), random US/MA | Increase of blood flow volume |
| Wang et al133 | LS | Right LI4 | Healthy | 28 volunteers, random LA-LI4/LA-non LI4 | Increase of left LI4 MBF, 40 min later after stimulation ceased, the MBF still increasing significantly |
| Raith et al134 | LS | LI4 | Premature neonates | 10 neonates (7 m, 3 f), initial temp/5 min stim temp/10 min stim temp | Increase in the skin temperature |
| Lee et al178 | MS | PC9 | Healthy | 1 individual | Parasympathetic activity of the autonomic nervous system |
| Jia et al179 | EA | Bi ST36, ST37 | Healthy | 20 volunteers, EA/sham EA | Effect on autonomic function |
| Jones et al180 | TEAS | Bilateral PC6 | Healthy | 16 volunteers, random TEAS/sham-TEAS non-APs/no TEAS no-stim | Change in artery |
| Lee et al181 | EA | LI4, LI11 | Healthy | Randomized crossover design, 14 participants, HF-EA 120 Hz/LF-EA 2 Hz | Increase in autonomic nervous activity (HF-EA), enhancing sympathovagal balance (both) |
| Chang et al182 | EA | ST36, LI10 | Healthy | 15 volunteers, LF EA (low freq. 2 Hz)/HF EA (high freq. 100 Hz) | Not affecting cardiovagal activity in normal volunteers |
| Cunha et al140 | LS/MA | 10 acupoints | Circulatory deficiency | 40 individuals, LS (20)/MA (20) | Significant increase in systolic pressure of lower limbs, consequent improvement of the revascularization index |
| Litscher et al135 | LS | PC6 | Healthy | Randomized, controlled study, 13 volunteers, LS/control-laser off | Decrease of HR |
| Kim et al183 | EA | PC5, PC6 | Healthy | EA (10)/sham-EA no stim (10) | EEG, ECG, HR change |
| Lu et al184 | MA, EA, TENS | Bi ST36, ST37, palm, dorsum | Healthy | 20 volunteers, random sham-MA/MA/EA/TENS; before-A, during-A, after-A (time sequence) | Cutaneous blood flow & temperature change |
| Zhang et al185 | TEAS | LI4, LI11 | Normal & elevated blood pressure | Randomly, 27 individuals, TEAS (13, 8 m, 5 f)/control (14, 9 m, 5 f) | Reduction of systolic blood pressure, but not diastolic blood pressure |
| Zhang et al136 | LS | LI4, LI11 | Healthy | Randomized controlled pilot study, 45 students + faculty, LA/sham-LA laser off | Reduction of blood pressure |
| Cakmak et al186 | EA | ST29, ST25 | Healthy (m) | Prospective, randomized study, 80 volunteers, MA/2 Hz-EA/10 Hz-EA | Increase in testicular blood flow, helpful in clinical treatment of infertile men (ST29, 10 Hz) |
| Arai et al187 | TEAS | Bi PC5, PC6/shoulder | Parturients undergoing cesarean section under spinal anesthesia | Random, 36 singleton parturients, TEAS (12)/sham-APs TEAS (12)/no treatment (12) | Reduction of the severity & incidence of hypotension after spinal anesthesia in parturients |
| Cheung & Jones188 | TEAS | Bilateral PC6 | Healthy (m) | Single-blinded, randomized controlled trial, 28 individuals, treadmill, TEAS/pre-TEAS/placebo-TEAS | HR recovery after exercise |
| Banzer et al137 | LS | Right forearm PC6 | Healthy (nonsmoking males) | Randomized, double-blinded, placebo-controlled trial, 33 healthy (m), LA (18)/control no laser (15) | Improvement of blood flow |
| Szeles & Litscher189 | AEA | Ear acupuncture | Healthy (f) | 2 healthy (f), AEA | Modulation of blood flow |
| Litscher138 | LS | Acupuncture points | Healthy | Randomized crossover study, 22 volunteers, LS | Changes in peripheral microcirculation & surface temperature of skin |
| Li et al190 | MS (magnitopuncture) | GV14, PC6 | Healthy (m) | Randomly, 40 individuals, MS/control MS non-APs | Modulating effect on sympathetic & parasympathetic nerve activities |
| Hsieh et al191 | EA | ST36 | Healthy | 8 volunteers, before/during /after EA | Physiological mechanisms responsible |
| Litscher & Schikora139 | LS | Vision-related acupoints | Healthy | Randomized crossover trial, 27 volunteers (13 m, 14 f), LA/MA | Increases of blood flow in ophthalmic artery |
| Cramp et al192 | TENS/TEAS | Median nerve/LI4 | Healthy | Randomly, 30 individuals (15 m, 15 f), control (10)/TENS (10)/TEAS (10) | Increase in cutaneous blood flow in the TENS median nerve |
| Litscher et al141 | LS | Vision-related acupoints | Healthy | 15 volunteers (10 m, 5 f), LS/MA | Increases in blood flow velocity in posterior cerebral artery |
| Balogun et al193 | TEAS (HVG) | ST36, ST37 | Healthy | 11 individuals (5 m, 6 f), 2 Hz-TEAS/120 Hz-TEAS | No increase in peripheral hemodynamic functions in asymptomatic individuals |
| Williams et al194 | TEAS | LR3, ST36, LI11 | Diastolic hypertension | Random, 10 individuals, TEAS/sham-TEAS non-APs. | Reduction of diastolic blood pressure for TEAS |
| Dunn et al., 195 | TEAS | SP6, LR3 | Pregnant women | Randomly, TEAS/control no stim | Increase in frequency & strength of uterine contractions |
AEA, auricular electroacupuncture; AP, acupuncture point; ASD, acupuncture-like stimulation device; EA, electroacupuncture; ECG, electrocardiogram; EEG, electroencephalogram; f, female; HF, high frequency; HR, heart rate; HRV, heart rate variability; HVG, high voltage galvanic; LA, laser acupuncture; LF, low frequency; LS, laser stimulation; m, male; MA, manual acupuncture; MBF, meridian blood flow; MS, magnetic stimulation; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation; US, ultrasound stimulation.
Table 11
Summary of studies on the treatment of various diseases with the four ASDs
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Sun et al142 | EA | Bilateral PC6 | OI | Randomized, controlled, crossover design, EA (20)/no EA (10) | Treatment in attenuating OI |
| Zhang et al196 | TEAS | LI4, PC6, ST36, SP6 | Autistic children receiving rehabilitation training | 76 children, TEAS (37)/no treatment (39) | Effective for treatment of autistic children with passive & aloof social interaction style |
| Yang et al197 | TEAS | LI4, SJ5, ST36, BL63, LR3, GB40 | Supratentorial craniotomy | Randomized controlled trial, EA/sham-EA | Significantly shortened speed of postoperative recovery |
| Sahmeddini et al198 | EA | PC6, PC5 | End-stage liver disease patients undergoing orthotropic deceased donor liver transplantation | Randomized, 40 patients, norepinephrine-vasoconstrictor/EA | Reduction of severity & incidence of hypotension during anesthesia for liver transplantation |
| Ng et al199 | TEAS | Bi PC6 | Open heart surgery | 40 patients, random TEAS (20)/placebo-TEAS no stim (20) | Earlier return to preoperative BP, HR, & RPP values |
| Wang et al200 | MA/EA | Bi GB8, TE17, GB2, GB20, GV20, TE3, ST36 (MA)/bi GB8, TE17 (EA) | Tinnitus | Randomized, single-blinded, placebo-controlled design, 50 patients (46 m, 4 f), MA/EA/placebo | Short-term general effects on tinnitus (EA) |
| O’Brien et al201 | LS | 10 acupoints | Active symptoms of menopause | Double-blind, randomized, placebo-controlled study, 40 women, LS/placebo LS (off) | Treatment of menopausal symptoms (no more efficacious than MA) |
| Ngai et al202 | TEAS | Bi EX-B1, LU7 | Patients with asthma | Randomized controlled trial, 30 individuals, random TEAS/TEAS + ST/sham-TEAS + ST | Reduction in the decline of forced expiratory volume in 1s FEV (1) following exercise training |
| Burduli & Ranyuk203 | LS + ST | Acupuncture points | Chronic noncalculous cholecystitis | 73 patients, ST (35)/LA + ST (38) | Cholecystitis treatment |
| Su et al204 | LS | Acupoints | Renal failure patients receiving regular hemodialysis | Randomized controlled trial, before/after LS | Decrease in both stress & fatigue levels |
| Lau & Jones205 | TEAS | Bi Ex-B1 | Chronic obstructive pulmonary disease | Randomized, placebo-controlled trial, 46 patients, TEAS/placebo-TEAS no stim | Management of dyspnea |
| Hsu et al206 | EA | BL15 | Healthy | 10 volunteers, sham-EA/2 Hz-EA | Relaxation, calmness, & reduced feeling of tension or distress |
| Bray et al207 | EA | Uni PC6, HT3, LR3/bi GB34, LI11, SI3 | Healthy | 80 individuals, EA-PC6, HT3, LR3/ EA-GB34, LI11, SI3/no stim; 5/60/100 Hz; uni/bilateral | Adjunct therapy for disorders of hypervigilance (to decrease arousal levels) |
| Litscher et al208 | LS | ST7, TE22 | Intensive care patient after severe head injury | 34 volunteers (10 m, 24 f), 1 patient (head injury), acupressure/MA/LA | Reproducible functional changes in the brain |
| O’Reilly et al209 | LS | SP6 | Interstitial cystitis | Double-blind trial, random LS (29)/placebo (27) | Treatment & control cohorts experiencing similar improvements, no difference between active & sham |
| Li et al210 | MS | GV14, PC6 | Healthy | Randomly, 40 individuals, MS/control MS non-APs | Effects of driving fatigue |
AP, acupuncture point; ASD, acupuncture-like stimulation device; BP, blood pressure; EA, electroacupuncture; f, female; FEV1, forced expiratory volume in 1 second; HR, heart rate; LA, laser acupuncture; LS, laser stimulation; m, male; MA, manual acupuncture; MS, magnetic stimulation; OI, orthostatic intolerance; RPP, rate pressure product; ST, standard treatment; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation.
Table 12
Clinical studies showing miscellaneous characteristics
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Chen et al143 | LS | LU9, PC7, HT7, SI4, SJ4, LI5, SP3, LR3, KI4, BL65, GB40, ST42 | Healthy | 76 candidates | Complementary & interaction for current flow of meridians |
| Gopalan et al211 | EA | Acupuncture points | Implanted with cardiac device | – | Safety in patients with a total artificial heart |
| Irnich et al212 | LS/Seirin (sham-LS) | LI4, LU7, LR3 | Healthy | Randomized, double-blinded, crossover design, 34 volunteers, LS (18)/sham-LS (16) | Valid placebo control in laser acupuncture studies (Seirin) |
| Litscher & Wang213 | MA/LS | LU6 | Healthy | 1 person, MA/LA | Changes of electrical skin impedance |
| Thompson & Cummings214 | EA | Acupuncture points in a limb | Healthy | – | No detectable currents in the chest (safety) |
| Leung et al215 | TEAS/MA/EA | LI4 | Healthy | 15 individuals, TEAS/MA/EA | Difference in electrical conductance between APs & non-APs |
| Litscher et al216 | LS | Acupuncture points | Healthy | 29 volunteers (9 m, 20 f), LA/placebo-LA; before/after | Change in the median value of cold pain, no significant changes in parameters of thermal sensory & pain thresholds |
| Chang et al., 217 | EA/TEAS | Left LI4 | Healthy | 13 volunteers, 2 Hz-EA/2 Hz-TEAS/100 Hz-TEAS | Changes of cutaneous reflex |
AP, acupuncture point; EA, electroacupuncture; f, female; LA, laser acupuncture; LS, laser stimulation; m, male; MA, manual acupuncture; TEAS, transcutaneous electrical acupoint stimulation.
Table 13
Summary of studies on the effect of the four ASDs on brain activity
| Reference | Stimulation type | Stimulation site | Symptom | Control | Effect |
|---|---|---|---|---|---|
| Guo et al., 144 | MS | PC6 | Healthy | 6 right-handed volunteers (3 m, 3 f) | Brain activity |
| Zhang et al145 | MS | Left GB37 | Healthy | GB37-MS/mock point-MS | Brain activity |
| Raith et al146 | LS | Bi LI4 | Term & preterm neonates | 20 neonates (12 m, 8 f), LA period/postintervention period | Brain activity |
| Quah-Smith et al147 | LS | LR8 | Healthy | 16 participants, random on–off block design, LA/MA | Brain activity |
| Zhang et al148 | TEAS | LI4, PC8 | Healthy | 18 individuals (9 m, 9 f), all individuals TEAS | Brain activity |
| Yin et al149 | MS | PC6 | Healthy | — | Brain activity |
| Lee et al150 | MS | PC9 | Healthy | — | HRV & brain activity |
| Litscher151 | LS | PC6 | Healthy | 40 volunteers, LA/MA | Brain activity |
| Wu et al152 | LS | Palm | Healthy | single-blind randomized trial, 40 individuals (m), random LS (20)/sham LS (20) | Brain activity |
| Litscher et al153 | LS | Bi PC6 | Healthy (f) | 1 volunteer (f), LA | Brain activity |
| Yu et al154 | MS | PC6 | Healthy | MS-PC6/ MS-mock point | Brain activity |
| Jiang et al., 155 | TEAS | LI4, PC8 | Healthy | 40 individuals, TEAS (40) | Brain activity |
| Hsieh et al156 | LS | KI1 | Healthy right handed | 36 right-handed volunteers, random MW LA (12; 8 m, 4 f)/CW LA (12; 9 m, 4 f)/placebo LA(12) | Brain activity |
| Yu et al157 | MS | PC6 | Healthy | before MS/during MS/after MS | Brain activity |
| Kim et al158 | MS | PC9 | Healthy | — | Vascular & brain activity |
| Jo & Jo159 | MS | HT4, HT6 | Healthy | 23 young adults (aged 19–22 y) | Brain activity (pole direction) |
| Zyloney et al160160 | EA | LI3, LI4 right hand | Healthy, right handed | 48 individuals, random EA/sham EA | Brain activity |
| Quah-Smith et al161 | LS | LR14, CV14, LR8, HT7 | Healthy | 10 individuals, random LA/LA-sham point | Brain activity |
| Xu et al162 | MS | ST36, LI4 | Healthy | MS/MS-mock point | Brain activity |
| Na et al163 | EA | GB34 | Healthy | 12 individuals, EA/EA-sham points, | Brain activity |
| Xu et al164 | MS | ST36 | Healthy | Pre-MS/post-MS (0.5 Hz/1 Hz/3 Hz) | Brain activity |
| An et al165 | EA | LI4, LI11 | Healthy | Brain SPECT EA (20)/PET EA (13); before/during /after EA | Brain activity |
| Wang et al166 | EA | Right LI4 | Healthy | EA (9)/sham-point EA (5) | Brain activity |
| Zeng et al167 | EA | LI4 | Healthy (right handed) | EA | Brain activity |
| Litscher et al168 | LS | Acupoints | Healthy | Randomized controlled crossover trial, 18 volunteers (7 m, 11 f), before/during-LA/after | Modulation of blood flow, brain activity |
| Zhang et al169 | EA | Left leg ST36, SP6 | Healthy (right handed) | 48 individuals, 2 Hz-EA/100 Hz-EA | Analgesia effect/brain activity |
| Li et al170 | EA | TE8, GV15 | Healthy (Chinese males) | 17 volunteers (m), EA-TE8 (11)/EA-GV15 (6) | Brain activity, typical language areas in the left inferior frontal cortex not activated |
| Kong et al171 | EA | Left hand LI4 | Healthy (right handed) | 11 volunteers (6 m, 5 f), EA/MA | Brain activity |
| Siedentopf et al172 | LS | Left foot BL67 | Healthy (m) | 10 volunteers (m), LA/dummy LA | Brain activity |
| Wu et al173 | EA | GB34 | Healthy | 45 volunteers, EA (15)/mock-EA no stim (7)/minimal-EA superficial & light stim (8)/sham-EA non-Aps (15) | Modulation of hypothalamus limbic system |
| Chang et al174 | MA/TEAS | LI4 | Healthy | Randomly, control TEAS no stim/MA/2 Hz-TEAS/100 Hz-TEAS | Increases in amplitude of H-reflex (TEAS), 100 Hz TEAS has greater effect |
AP, acupuncture point; ASD, acupuncture-like stimulation device; EA, electroacupuncture; f, female; HRV, heart rate variability; LA, laser acupuncture; LS, laser stimulation; m, male; MA, manual acupuncture; MS, magnetic stimulation; PET, positron emission tomography; SPECT, single-photon emission computed tomography; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation.
4. Discussion
EAs, which are invasive types of ES, were the first and most intensively studied modern applications of ASDs. Recently, the number of publications regarding the clinical effectiveness of noninvasive stimulations, such as TEAS, LS, MS, and US, has been increasing (Fig. 3). The increase is more substantial for noninvasive acupuncture-like techniques, most likely due to the growing demands for painless acupuncture or acupoint stimulations. Among the 195 articles analyzed, the studies involving ES (EAs and TEASs) predominated (133 articles, 68%), followed by LS studies (44 articles, 23%). Studies involving MS (16 articles, 8%) or US (2 articles, 1%) were less common. The publication of ES studies has steadily increased since the early 2000s, whereas LS and MS showed similar increment patterns with delayed start-up points (i.e., the increases began in 2009 and 2011, respectively). Despite its long history, ES had a steady but limited publication rate prior to 2000, whereas during the 1980s and 1990s, the number of publications on ES remained between zero article and two articles per year.
The number of published articles on the four ASDs per year.
ASD, acupuncture-like stimulation device; ES, electrical stimulation; LS, laser stimulation; MS, magnetic stimulation; US, ultrasound stimulation.
Fig. 4 shows the yearly publications of invasive (EAs) and noninvasive (TEASs) ES techniques. The total number of studies was similar between EAs (63 articles) and TEASs (70 articles). However, differences were observed in the number of publications per year; the publications associated with TEASs showed a steady increase over time, which is in contrast to the stable annual publication pattern of EAs. Notably, the number of TEAS publications surpassed that of EAs in 2010. Specifically, TEASs were studied more than EAs over the past 5 years in the context of diseases with high therapeutic benefits, such as analgesic effect, pain relief, improvement of the alimentary system, and prevention of nausea and vomiting. The rising popularity of TEASs is presumably due to the increasing needs for safety without needling, low infection risk, and relatively expedient utilization of clinical trials. The recent increase in studies of LS and MS, which are noninvasive, may be understood based on the same rationale.
The number of articles on ES methods with years, where EAs include the invasive techniques of EA, AEA, and EHA, and TEASs include the noninvasive techniques of TEAS and TENS.
AEA, auricular electroacupuncture; EA, electroacupuncture; EHA, electrical heat acupuncture; ES, electrical stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation.
According to a recent analysis, approximately 41% of clinical studies in acupuncture research from 1991 to 2009 addressed pain and analgesia.6 Among the studies evaluating the four types of ASDs published through 2014, the percentage of clinical studies addressing pain and analgesia was 33%. This reduction in the percentage of studies focused on pain and analgesia is directly related to the recently heightened interest in acupuncture research on brain activities. The percentage of publications focused on brain activities that have been published since 2010 constitutes 61% (19 articles) of all such publications since 2001 (31 articles). Excluding the emerging category of brain activity, approximately 38% of the studies were focused on pain and analgesia, which is similar to the percentage of MA studies focused on pain and analgesia.
The effectiveness analysis showed that the effectiveness of ES with respect to the analgesic effect, pain relief, and reduction of nausea and vomiting was confirmed by clinical trials involving > 1000 individuals and many RCTs. Based on clinical trials involving > 100 individuals, ES was effective in improving the alimentary system, improving muscle strength, reducing body weight, and treating stroke. Likewise, LS was shown to be useful for providing pain relief and in treating various addictions. Interestingly, the addiction treatment effect was confirmed by LS studies but not by ES studies.
4.1. Limitations
Our review is based on the four most influential databases, specifically Medline, PubMed, Cochrane Library, and Web of Science; moreover, we primarily analyzed Science Citation Index (SCI) or Science Citation Index Expanded (SCI-E) journal articles. The advantage of this approach is the inclusion of quality-guaranteed articles only. Laboratory experiments on animals, MA-only clinical trials, non-English-language articles, and review articles were excluded from the analysis. The details regarding device specifications or interventional designs, including stimulation strength, duration and interval, and patient and environmental conditions, were not analyzed due to space limitations.
5. Conclusions
In the past decade, modern ASDs have been studied extensively for their clinical effectiveness and to test equivalence or noninferiority with traditional MA. Among the modern ASDs, ES was found to be most widely studied, and its popularity was sequentially followed by LS, MS, and US. Specifically, EAs, which are invasive types of ES, were the first and most intensively studied types of ASDs, whereas TEASs, which are noninvasive types of ES, have surpassed EAs in publication number since 2010. Very recently, noninvasive techniques, such as TEASs, LS, MS, and US have gained research attention, as evidenced by increasing annual publications.
The most extensively studied treatment effects were for analgesia and pain relief, whereas rapid growth has occurred in the research field of the effects of treatments on brain activities. The overall quality of the study designs was moderate, as 58% of the studies were based on RCTs and 96% of the RCT-based outcomes reported therapeutic benefits. ES was effective in providing an analgesic effect, pain relief, and a reduction of nausea and vomiting, based on clinical trials involving > 1000 individuals. Based on > 100 clinical trials, ES was shown to be effective in improving the alimentary system, improving muscle strength, reducing body weight, and treating stroke. LS was effective in pain relief and for treating various addictions. We anticipate more studies on the therapeutic effects of ASDs, particularly concerning noninvasive methods, to meet the growing needs of guaranteed safety, decreased risk of infection, decreased pain, and improved convenience.
Conflicts of interest
No conflicts of interest are declared.
Acknowledgments
This work was supported by a grant (K15012) from the Korea Institute of Oriental Medicine, Daejeon, Korea, funded by the Korean government.




